Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-31

Study Completion Date

2021-03-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study

NCT02865473

Glaucoma

UNKNOWN NA

The Effect of Pseudoexfoliation on Choroidal Thickness in Open Angle Glaucoma

NCT03373942

Glaucoma, Open-Angle

COMPLETED

Efficacy and Safety of Lens Extraction in Patients With Pseudoexfoliation Glaucoma

NCT03494465

Pseudoexfoliation Glaucoma Intraocular Pressure

COMPLETED NA

Micropulse Laser Trabeculoplasty as Adjunctive Treatment in Patients With Pseudoexfoliation Glaucoma

NCT03483402

Pseudoexfoliation Glaucoma Primary Open-angle Glaucoma

COMPLETED NA

Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma

NCT00327613

Pseudoexfoliation Syndrome Glaucoma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lens Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

includes patients who will be diagnosed with Pseudoexfoliation syndrome

slit lamp

Intervention Type DEVICE

1. Presence of white grayish exfoliation material on the anterior lens capsule and / or the pupillary margin.
2. Poor pupillary dilatation due to atrophy of the dilator pupillae muscle.
3. The presence of pseudoexfoliative material (PXF)in cilliary processes and zonules.
4. presence of PXF material scattered on corneal endothelium.
5. Flecks of the exfoliative material on the anterior chamber which leads to glaucoma.

control group

age matched controls who do not have Pseudoexfoliation syndrome

slit lamp

Intervention Type DEVICE

1. Presence of white grayish exfoliation material on the anterior lens capsule and / or the pupillary margin.
2. Poor pupillary dilatation due to atrophy of the dilator pupillae muscle.
3. The presence of pseudoexfoliative material (PXF)in cilliary processes and zonules.
4. presence of PXF material scattered on corneal endothelium.
5. Flecks of the exfoliative material on the anterior chamber which leads to glaucoma.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

slit lamp

1. Presence of white grayish exfoliation material on the anterior lens capsule and / or the pupillary margin.
2. Poor pupillary dilatation due to atrophy of the dilator pupillae muscle.
3. The presence of pseudoexfoliative material (PXF)in cilliary processes and zonules.
4. presence of PXF material scattered on corneal endothelium.
5. Flecks of the exfoliative material on the anterior chamber which leads to glaucoma.

Intervention Type DEVICE